Comparison of benign and malignant body cavity effusio
Not Applicable
- Conditions
- Health Condition 1: C76- Malignant neoplasm of other and ill-defined sites
- Registration Number
- CTRI/2024/06/069527
- Lead Sponsor
- Maulana Azad medical college
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All cases of body cavity effusion in individuals aged 18 years or more
Exclusion Criteria
Cases with less than 2ml or degenerated fluid.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Total and differential leukocyte counts in body cavity effusion <br/ ><br>2. Proportion of cases showing expression of Ep-CAM, CD14 and CD45 in suspicious cases or cases with malignancyTimepoint: Baseline
- Secondary Outcome Measures
Name Time Method Association of cytological features <br/ ><br>(presence of reactive mesothelial cells, atypical mitosis, cytological atypia, presence of <br/ ><br>three-dimensional clusters) with clinical parameters (weight loss, biochemical <br/ ><br>parameters, radiological details, stage of the disease)Timepoint: Baseline